Regeneron Pharmaceutical (NASDAQ:REGN) fell 2% after a court rejected its request for a temporary injunction blocking sales ...
Analyst Terence Flynn from Morgan Stanley maintained a Hold rating on Amgen (AMGN – Research Report) and keeping the price target at ...
An investor is suing Amgen Inc.'s leaders over the company’s $10.7 billion fight with the IRS, which has said the ...
At the STAT summit, executives discuss their challenges, and hopeful signals, about breaking into markets on obesity and ...
TD Cowen analyst Yaron Werber maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $383.00. Yaron ...
As for Lilly ( LLY ), Bernstein said its outperform rating “hinges on what they can do with the cash they generate from ...
OLD National Bancorp IN lessened its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 4.0% during the 3rd ...
Amgen (NASDAQ: AMGN) stock is up 13% this year but has struggled to break out above a tight trading range in recent months. Despite a string of solid earnings reports from the biotechnology giant ...
Recent health news includes Amgen's launch of an Eylea biosimilar in the U.S., Slovakia's bird flu outbreak, and China's ...
Blue Trust Inc. boosted its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 46.3% during the third quarter, ...